| The raging of the new crown epidemic has made nucleic acid detection in the field of molecular diagnostics well known to the public.This technology can detect the nucleic acid sequence of genetic material and is used in laboratories to identify and detect certain specific organisms,such as bacteria or viruses.So far,nucleic acid detection A positive test remains the gold standard for diagnosis.According to the "Report on the Form of China’s Foreign Trade"(Autumn 2021),affected by the surge in global demand for epidemic prevention,the export delivery value of the pharmaceutical manufacturing industry is in a stage of rapid growth,and the export value of medical devices in the first ten months of 2021 will reach 106.74 billion yuan.A year-on-year increase of 2.4%.As an in vitro diagnostic foreign trade company,LP Company,in the fierce export competition in the same industry,has also exposed certain problems while pursuing high demand for performance,such as insufficient production capacity,insufficient R&D and innovation capabilities,untimely grasp of overseas market demand,Insufficient overseas marketing capabilities,etc.,in turn affected the sales and product competitiveness of foreign trade exports.This thesis takes the molecular diagnostic products of LP Company as the breakthrough point,analyzes the problems encountered in product export,and summarizes the problem indicators that affect the export competitiveness of molecular diagnostic products.First,using the Decision-making Trial and Evaluation Laboratory(DEMATEL),using the experience judgment data of the company’s foreign trade departments on the problem indicators,the direct impact matrix of the 13 problem indicators is constructed,and then the comprehensive impact matrix is calculated,and the influence degree of each factor is obtained.And the ranking of influence degree,centrality degree and cause degree,to effectively screen the influencing factors of LP’s molecular diagnostic products export competitiveness and find out the key influencing factors,the results show that the inventory management model needs to be improved,and it is not timely to grasp the overseas market demand The centrality of fierce competition with peers is high,which is a key issue indicator affecting the export of LP’s molecular diagnostic products.Then use the Interpretive Structure Model(ISM)to build a multi-level hierarchical structure,analyze the connection and hierarchical relationship of each factor,and finally combine the results of the cause-and-effect diagram to sort the importance of the influencing factors,and find out the surface factors and deep factor.And the fundamental influencing factors,the results show that the surface factors are the inventory management model to be improved,the product line is relatively simple,the technology maturity is not high,and the deep factor are the lack of control over raw material procurement,lack of R&D and innovation capabilities,international trade environment issues,production capacity Insufficient,internal process management problems of the enterprise,untimely grasp of overseas market demand and other indicators,and the fundamental factor is the fierce competition in the industry.By integrating the DEMATEL/ISM method,the problem of exporting molecular diagnostic products of LP enterprises is analyzed,and corresponding optimization countermeasures are formulated for important problem indicators,thereby enhancing the export competitiveness of molecular diagnostic products.It provides a certain reference value for the overseas market expansion and international strategic deployment of the molecular diagnostic industry in the post-epidemic era. |
